Method matters: a comparative evaluation of tissue-derived extracellular vesicle isolation methods in non-small cell lung cancer
Tumor-derived small extracellular vesicles (sEVs), including exosomes, affect immune cell function and contribute to the establishment of an immunosuppressive tumor microenvironment. Most studies on tumor-derived sEVs focus on vesicles isolated from cancer cell-conditioned media, but these may differ substantially from those present in the native tumor microenvironment. Direct isolation of sEVs from tumor tissue offers a more biologically relevant approach, but isolated material is often contaminated with intracellular material, protein aggregates, and blood-derived components, making the choice of isolation method critical for reliable downstream analyses. In this study, we compared six EV isolation methods for non-small cell lung cancer tissue: ultracentrifugation, iodixanol-cushioned ultracentrifugation, and four commercial kits based on vesicle precipitation, membrane affinity, immunoaffinity, and phosphatidylserine binding. Using transmission electron microscopy, CD9-targeted fluorescence nanoparticle tracking analysis, and quantitative LC-MS/MS proteomics, we assessed the isolated preparations based on characteristics relevant to sEV characterization, including particle size, vesicle morphology, CD9⁺ particle abundance, and EV-associated protein enrichment. Ultracentrifugation and iodixanol-cushioned ultracentrifugation yielded samples showing the strongest evidence of sEV enrichment, as indicated by vesicle morphology, abundance of CD9⁺ particles, and enrichment of EV-associated proteins. The phosphatidylserine-binding approach resulted in moderate sEV enrichment, whereas the other tested approaches predominantly isolated non-vesicular contaminants. While iodixanol-cushioned ultracentrifugation achieved the highest purity, ultracentrifugation provided comparable purity with considerably higher yield of CD9⁺ particles, used here as a proxy for sEV recovery. Overall, ultracentrifugation offers the best balance between purity and isolation efficiency, making it a practical choice for tissue-derived EV studies and downstream molecular analyses in solid tumors.
Authors
- Anna Biernacka (ORCID: https://orcid.org/0000-0002-0080-5947)
- Danuta Gutowska‐Owsiak (ORCID: https://orcid.org/0000-0003-4503-2279)
- Witold Rzyman (ORCID: https://orcid.org/0000-0002-9044-7791)
- Sachin Kote (ORCID: https://orcid.org/0000-0002-2431-9935)
- Jakub Faktor (ORCID: https://orcid.org/0000-0002-8232-9787)
- Aneta Zebrowska (ORCID: https://orcid.org/0000-0001-6049-301X)
- Zuzanna Urban‐Wójciuk (ORCID: https://orcid.org/0000-0002-5868-1991)
- Magdalena Sitkiewicz (ORCID: https://orcid.org/0000-0003-3492-5629)
- Monika Pietrowska (ORCID: https://orcid.org/0000-0001-9317-7822)
- Artur Piróg (ORCID: https://orcid.org/0000-0001-5049-043X)
- Magdalena Szczepanowska (ORCID: https://orcid.org/0000-0003-4552-6156)
- Natalia Maria Marek-Trzonkowska (ORCID: https://orcid.org/0000-0003-1201-295X)
- Ines Papak (ORCID: https://orcid.org/0000-0002-0174-8526)
- Tomasz Marjański (ORCID: https://orcid.org/0000-0002-1260-3269)
- Martyna Siewiera
Institutions
- Medical University of Silesia (PL)
- University of Gdańsk (PL)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Gdańsk Medical University (PL)
- Polish Academy of Sciences (PL)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1186/s12964-026-03355-4
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00